Girish Naganathan - Nov 8, 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Chief Technology Officer
Signature
By: Christophe Cantenot For: Girish Naganathan
Stock symbol
DXCM
Transactions as of
Nov 8, 2022
Transactions value $
$31
Form type
4
Date filed
11/14/2022, 03:51 PM
Previous filing
Oct 11, 2022
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $31.40 +31.4K $0.00* 31.4K Nov 8, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 31,449 unvested restricted stock units, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.